Abstract
Despite the diversity of patient populations in the UK, underrepresentation of BAME individuals persists in clinical trials. Nasa-Marie Wright discusses these disparities and suggests strategies to improve minority representation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
